Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.

MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.

Stovall DW, Pinkerton JV.

Curr Opin Investig Drugs. 2009 Apr;10(4):365-71. Review.

PMID:
19337958
2.

Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.

Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, Levine KB, Jordan J, Clark RV.

Climacteric. 2008 Feb;11(1):32-43. doi: 10.1080/13697130701744696.

PMID:
18202963
3.

Use of a multibotanical (Nutrafem) for the relief of menopausal vasomotor symptoms: a double-blind, placebo-controlled study.

Garcia JT, Gonzaga F, Tan D, Ng TY, Oei PL, Chan CW.

Menopause. 2010 Mar;17(2):303-8. doi: 10.1097/gme.0b013e3181bf8e92.

PMID:
19934777
4.

MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.

Leitman DC, Christians U.

Expert Opin Investig Drugs. 2012 Jul;21(7):1031-42. doi: 10.1517/13543784.2012.685652. Epub 2012 May 23. Review.

PMID:
22616988
5.
6.

The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial.

Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG.

Med J Aust. 2001 Jan 15;174(2):68-71.

PMID:
11245505
7.

Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.

Wang PH, Horng HC, Cheng MH, Chao HT, Chao KC.

Taiwan J Obstet Gynecol. 2007 Jun;46(2):127-34. Review.

8.

The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.

Kwee SH, Tan HH, Marsman A, Wauters C.

Maturitas. 2007 Sep 20;58(1):83-90. Epub 2007 Aug 8.

PMID:
17689896
9.

Treating menopausal symptoms with a tissue-selective estrogen complex.

Levine JP.

Gend Med. 2011 Apr;8(2):57-68. doi: 10.1016/j.genm.2011.03.008. Review.

PMID:
21536225
10.

A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.

Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV.

Int J Fertil Womens Med. 2000 Jul-Aug;45(4):264-72.

PMID:
10997482
11.
13.

Vasomotor flushes in menopausal women.

Bachmann GA.

Am J Obstet Gynecol. 1999 Mar;180(3 Pt 2):S312-6. Review.

PMID:
10076170
17.

Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.

Villaseca P.

Climacteric. 2012 Apr;15(2):115-24. doi: 10.3109/13697137.2011.624214. Epub 2011 Dec 8. Review.

PMID:
22148909
18.

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.

Stovall DW, Utian WH, Gass ML, Qu Y, Muram D, Wong M, Plouffe L Jr.

Menopause. 2007 May-Jun;14(3 Pt 1):510-7.

PMID:
17314736
19.

Estrogen receptor beta and its selective ligands: an option for treatment of menopausal vasomotor symptoms?

Jarry H.

Horm Mol Biol Clin Investig. 2013 Dec;16(1):7-12. doi: 10.1515/hmbci-2013-0034.

PMID:
25436742
20.

Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.

Pinkerton JV, Stovall DW.

Expert Opin Investig Drugs. 2010 Dec;19(12):1613-21. doi: 10.1517/13543784.2010.532487. Epub 2010 Nov 13. Review.

PMID:
21073353

Supplemental Content

Support Center